{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:29:49Z","timestamp":1739338189973,"version":"3.37.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.etp.2009.07.007","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T08:36:27Z","timestamp":1250152587000},"page":"567-571","source":"Crossref","is-referenced-by-count":9,"title":["Phospholipidosis in healthy subjects participating in clinical studies: Ultrastructural findings in white blood cells"],"prefix":"10.1016","volume":"62","author":[{"given":"Andreas","family":"Pospischil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Walther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Dingemanse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etp.2009.07.007_bib1","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Minireview. Drug induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.etp.2009.07.007_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01926230701196414","volume":"35","year":"2007","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.etp.2009.07.007_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1388-1981(00)00055-X","article-title":"Intracellular cholesterol trafficking: role of the NPC1 protein","volume":"1486","author":"Blanchette-Mackie","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.etp.2009.07.007_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0002-9343(85)90346-8","article-title":"Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity","volume":"78","author":"Dake","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.etp.2009.07.007_bib5","first-page":"116","article-title":"Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs","volume":"35","author":"Drenckhahn","year":"1976","journal-title":"Lab Invest"},{"key":"10.1016\/j.etp.2009.07.007_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.etp.2009.07.007_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-5793(03)00100-5","article-title":"Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from nonneurologic Niemann\u2013Pick type C patients but also patients possibly affected with other lipid trafficking disorders","volume":"537","author":"Harzer","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.etp.2009.07.007_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0006-2952(81)90451-2","article-title":"Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C","volume":"30","author":"Hostetler","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.etp.2009.07.007_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1289\/ehp.7616111","article-title":"Pulmonary changes induced by amphiphilic drugs","volume":"16","author":"Hruban","year":"1976","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.etp.2009.07.007_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20995-8","article-title":"Types of interaction of amphiphilic drugs with phospholipid vesicles","volume":"246","author":"Joshi","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.etp.2009.07.007_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10408447509164014","article-title":"Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine","volume":"4","author":"L\u00fcllmann","year":"1975","journal-title":"CRC Crit Rev Toxicol"},{"key":"10.1016\/j.etp.2009.07.007_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"L\u00fcllmann","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.etp.2009.07.007_bib13","first-page":"49","article-title":"Drug-induced lysosomal storage disorders","volume":"vol. 6","author":"L\u00fcllmann-Rauch","year":"1979"},{"key":"10.1016\/j.etp.2009.07.007_bib14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1083\/jcb.97.4.1156","article-title":"Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells","volume":"97","author":"McGookey","year":"1983","journal-title":"J Cell Biol"},{"key":"10.1016\/j.etp.2009.07.007_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","author":"Reasor","year":"1989","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.etp.2009.07.007_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.etp.2009.07.007_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.ATV.8.1.57","article-title":"Ca11 antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes","volume":"8","author":"Robenek","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.etp.2009.07.007_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.etp.2009.07.007_bib19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0022-2275(20)41642-6","article-title":"Structure and function of lamellar bodies, lipid\u2013protein complexes involved in storage and secretion of cellular lipids","volume":"32","author":"Schmitz","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.etp.2009.07.007_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/112_2008_802","article-title":"Lipid homeostasis in macrophages \u2013 implications for atherosclerosis","volume":"160","author":"Schmitz","year":"2008","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.etp.2009.07.007_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","article-title":"Biochemical studies in Niemann\u2013Pick disease. I. Major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.etp.2009.07.007_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0301-0082(99)00036-2","article-title":"Antidepressant-induced lipidosis with special reference to tricyclic compounds","volume":"60","author":"Xia","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.etp.2009.07.007_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1091\/mbc.10.3.537","article-title":"High-affinity binding of the AP-1 adaptor complex to trans-Golgi network membranes devoid of mannose 6-phosphate receptors","volume":"10","author":"Zhu","year":"1999","journal-title":"Mol Biol Cell"}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299309002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299309002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:50:33Z","timestamp":1739299833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299309002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0940299309002164"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2009.07.007","relation":{},"ISSN":["0940-2993"],"issn-type":[{"type":"print","value":"0940-2993"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}